Eliminating Missed Opportunities for CKD Care

Holly Kramer^{1

2}, Talar Markossian¹

Affiliations

¹ Department of Public Health Sciences, Parkinson School of Health Sciences and Public Health, Chicago, IL.
² Division of Nephrology and Hypertension, Department of Medicine, Loyola University Chicago, Chicago, IL.

Editorial

Holly Kramer et al. Kidney Med. 2019.

. 2019 Sep 12;1(5):229-231.

doi: 10.1016/j.xkme.2019.07.008. eCollection 2019 Sep-Oct.

Holly Kramer^{1

2}, Talar Markossian¹

¹ Department of Public Health Sciences, Parkinson School of Health Sciences and Public Health, Chicago, IL.
² Division of Nephrology and Hypertension, Department of Medicine, Loyola University Chicago, Chicago, IL.

No abstract available

Comment on

Interventions to Improve Blood Pressure Control Among Socioeconomically Disadvantaged Patients With CKD: Kidney Awareness Registry and Education Pilot Randomized Controlled Trial.
Tuot DS, Rubinsky AD, Velasquez A, McCulloch CE, Schillinger D, Handley MA, Hsu CY, Powe NR. Tuot DS, et al. Kidney Med. 2019 Aug 30;1(5):242-252. doi: 10.1016/j.xkme.2019.07.004. eCollection 2019 Sep-Oct. Kidney Med. 2019. PMID: 32734204 Free PMC article.

1. Kramer H.J., Townsend R.R., Griffin K. KDOQI US commentary on the 2017 ACC/AHA hypertension guideline. Am J Kidney Dis. 2019;73(4):437–458. - PMC - PubMed
1. Taler S.J., Agarwal R., Bakris G.L. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for management of blood pressure in CKD. Am J Kidney Dis. 2013;62(2):201–213. - PMC - PubMed
1. Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int Suppl. 2012;2(5):337–414.
1. Tonelli M., Wanner C., Kidney Disease: Improving Global Outcomes Lipid Guideline Development Work Group Members Lipid management in chronic kidney disease: synopsis of the Kidney Disease: Improving Global Outcomes 2013 clinical practice guideline. Ann Intern Med. 2014;160(3):182. - PubMed
1. Perkovic V., Jardine M.J., Neal B. Canagliflozin and renal outcomes in type 2 diabetes and nephropathy. N Engl J Med. 2019;380(24):2295–2306. - PubMed